Ron Pithawalla

Mutations Conferring Resistance to a Potent Hepatitis C Virus Serine Protease Inhibitor In Vitro

Liangjun Lu, Kent D. Stewart, John T. Randolph et al. · Antimicrobial Agents and Chemotherapy · 2004 · 164 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology

Teresa I. Ng, Hongmei Mo, Yupeng He et al. · Hepatology · 2007 · 129 citations · Full text

Life Sciences, Biology, Molecular Biology +17

Mutations Conferring Resistance to a Hepatitis C Virus (HCV) RNA-Dependent RNA Polymerase Inhibitor Alone or in Combination with an HCV Serine Protease Inhibitor In Vitro

Hongmei Mo, Liangjun Lu, Ron Pithawalla et al. · Antimicrobial Agents and Chemotherapy · 2005 · 120 citations

Life Sciences, Infectious Diseases, Molecular Biology +17

<i>In Vitro</i> and <i>In Vivo</i> Antiviral Activity and Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor ABT-450

Rakesh Tripathi, Daniel E. Cohen, I. Gaultier et al. · Antimicrobial Agents and Chemotherapy · 2014 · 117 citations

Life Sciences, Infectious Diseases, Pharmacology +17

<i>In Vitro</i> Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir

Teresa I. Ng, Rakesh Tripathi, Thomas Reisch et al. · Antimicrobial Agents and Chemotherapy · 2017 · 91 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13